The value of tandem mass spectrometry in high risk infants with primary carnitine deficiency

CHEN Da-yu; LI Zhe-tao; TAN Jian-qiang; ZHENG Min

doi:10.11852/zgetbjzz2017-25-02-29

PDF(463 KB)

Chinese Journal of Child Health Care ›› 2017, Vol. 25 ›› Issue (2) : 206-207. DOI: 10.11852/zgetbjzz2017-25-02-29

The value of tandem mass spectrometry in high risk infants with primary carnitine deficiency

CHEN Da-yu,LI Zhe-tao,TAN Jian-qiang,ZHENG Min

Author information +

History +

Abstract

Objective To investigate the carnitine spectrum metabolism level of high-risk children of primary carnitine deficiency by using tandem mass spectrometry (MS/MS) in 2 493 patients.And to value tandem mass spectrometry application in diagnosis of primary carnitine deficiency. Methods 2 493 cases of high-risk children suspected genetic metabolic disease were selected from January 2013 to 2016 April in authors' hospital.Carnitine spectrum were detected by tandem mass spectrometry screening and confirmed by gene sequencing. Results 55 patients (2.21%) were positive for carnitine metabolism disorders;10 patients (0.4%) were diagnosed as primary carnitine deficiency.There were five types of pathogenic mutation sites. Conclusion The incidence of primary carnitine deficiency in high-risk children is higher and the type of genic mutation is different from that in other regions.Tandem mass spectrometry technology is helpful to the early diagnosis of this disease in high-risk children and provide a basis for clinical diagnosis and treatments.

Key words

tandem mass spectrometry / high risk children / carnitine deficiency / acyl carnitine / gene

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

CHEN Da-yu,LI Zhe-tao,TAN Jian-qiang,ZHENG Min. The value of tandem mass spectrometry in high risk infants with primary carnitine deficiency[J]. Chinese Journal of Child Health Care. 2017, 25(2): 206-207 https://doi.org/10.11852/zgetbjzz2017-25-02-29

References

[1] 黄倬.原发性肉碱缺乏症诊治进展[J].临床儿科杂志,2012,30(9):884-886.
[2] 邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].北京:人民卫生出版社,2011:47.
[3] Magoulas PL,El-Hattab AW.Systemic primary carnitine deficiency:an overview of clinical manifestations,diagnosis,and management[J].Orphanet J Rare Dis,2012,18(7):68.
[4] 黄倬.原发性肉碱缺乏症发病机制及基因突变研究进展[J].中国实用儿科杂志,2012,27(5):393-395.
[5] 马艳艳,杨艳玲.原发性肉碱缺乏症与心肌病[J].中国实用儿科杂志,2014,29(10):738-741.
[6] Han LS,Wang F,Wang Y,et al.Analysis of genetic mutations in Chinese patients with systemic primary carnitine deficiency[J].Eur J Med Genet,2014,57(10):571-575.
[7] 程超,张雪元,李玖军.原发性肉碱缺乏症1例报告[J].中国当代儿科杂志,2014,16(9):952-954.
[8] 宋茂媛,刘长云.串联质谱分析在潍坊地区遗传代谢病诊治中的应用[J].辽宁医学院学报,2012,33(1):47-52.
[9] LL Yang,Huang XW,Yang JB,et al.Screening and diagnosis of children with primary carnitine deficiency in Zhejiang province,China[J].HK J Paediatr (New Series),2013,18(1):167-173.
[10] Wang SS,Rao J,Li YF,et al.Primary carnitine deficiency cardiomyopathy[J].Int J Gardiol,2014,174(1):171-173.
[11] 韩连书,叶军,邱文娟.等.原发性肉碱缺乏症17例诊治与随访[J].中华儿科杂志,2012,50(6):405-409.